Mitophagy Promotes Resistance to BH3 Mimetics in Acute Myeloid Leukemia
Phase I/1b Azacitidine + Sonidegib in Myeloid Neoplasms.
Daunorubicin/Cytarabine + Nilotinib in KIT-Expressing AML.
Safety, pharmacokinetics, and preliminary efficacy of E6201 in patients with advanced solid tumours, including melanoma: results of a phase 1 study
WEE1 Inhibition with AZD1775 Overcomes Azacitidine/Venetoclax Resistance in AML.
Titles as indexed on PubMed.